Summary:
Zydus Cadila on Thursday launched the cheapest generic version of Gilead Sciences` antiviral drug remdesivir in India to treat COVID-19 following reports of shortages at hospitals in the world`s third-worst hit nation.
Zydus has priced it at Rs 2,800 per 100mg vial. It will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients, the company said in a regulatory filing.
Officials in some Indian states had a few weeks ago complained of supply issues, but a top executive at drugmaker Cipla Ltd had earlier this week said the supplies were stabilising.
Zydus Cadila on Thursday launched the cheapest generic version of Gilead Sciences` antiviral drug remdesivir in India to treat COVID-19 following reports of shortages at hospitals in the world`s third-worst hit nation.
Zydus has priced it at Rs 2,800 per 100mg vial. It will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients, the company said in a regulatory filing.
Officials in some Indian states had a few weeks ago complained of supply issues, but a top executive at drugmaker Cipla Ltd had earlier this week said the supplies were stabilising.